Global DNA Repair Drugs Market Insights, Forecast to 2025

Publisher Name :
Date: 19-Jun-2019
No. of pages: 122
Inquire Before Buying

DNA damage leads to the incorporation of defects and aberrations in the genome that often result in functional mutations. When these mutations occur in genes coding for vital proteins and/or enzymes, it leads to the development of genetic diseases. However, our biological system is equipped with a robust repair mechanism capable of correcting damaged DNA sequences. PARP inhibitors and other similar therapeutics are designed to augment the body's innate DNA repair mechanism and aid in the treatment of diseases associated with genetic aberrations.

The global DNA Repair Drugs market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the DNA Repair Drugs market based on company, product type, end user and key regions.

This report studies the global market size of DNA Repair Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of DNA Repair Drugs in these regions.

This research report categorizes the global DNA Repair Drugs market by top players/brands, region, type and end user. This report also studies the global DNA Repair Drugs market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

- 4SC AG

- ARCAGY/ GINECO GROUP

- Bristol Myers Squibb

- British Columbia Cancer Agency

- Cambridge University Hospitals NHS Foundation Trust

- Genentech

- Georgetown University

- German Breast Group

- GlaxoSmithKline

- Jiangsu Hengrui Medicine

- Johnson & Johnson

- Jonsson Comprehensive Cancer Center

- Karyopharm Therapeutics

- KuDOS Pharmaceuticals

- National Health Service

- National Institutes of Health

- Tesaro

Market size by Product

- PARP Inhibitors

- Other

Market size by End User

- Oncological

- Stroke

Market size by Region

- North America

- - United States

- - Canada

- - Mexico

- Asia-Pacific

- - China

- - India

- - Japan

- - South Korea

- - Australia

- - Indonesia

- - Singapore

- - Malaysia

- - Philippines

- - Thailand

- - Vietnam

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Spain

- - Russia

- Central & South America

- - Brazil

- - Rest of Central & South America

- Middle East & Africa

- - GCC Countries

- - Turkey

- - Egypt

- - South Africa

The study objectives of this report are:

- To study and analyze the global DNA Repair Drugs market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.

- To understand the structure of DNA Repair Drugs market by identifying its various subsegments.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- Focuses on the key global DNA Repair Drugs companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.

- To project the value and sales volume of DNA Repair Drugs submarkets, with respect to key regions.

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of DNA Repair Drugs are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of DNA Repair Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global DNA Repair Drugs Market Insights, Forecast to 2025

Table of Contents
1 Study Coverage
1.1 DNA Repair Drugs Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global DNA Repair Drugs Market Size Growth Rate by Product
1.4.2 PARP Inhibitors
1.4.3 Other
1.5 Market by End User
1.5.1 Global DNA Repair Drugs Market Size Growth Rate by End User
1.5.2 Oncological
1.5.3 Stroke
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global DNA Repair Drugs Market Size
2.1.1 Global DNA Repair Drugs Revenue 2014-2025
2.1.2 Global DNA Repair Drugs Sales 2014-2025
2.2 DNA Repair Drugs Growth Rate by Regions
2.2.1 Global DNA Repair Drugs Sales by Regions
2.2.2 Global DNA Repair Drugs Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 DNA Repair Drugs Sales by Manufacturers
3.1.1 DNA Repair Drugs Sales by Manufacturers
3.1.2 DNA Repair Drugs Sales Market Share by Manufacturers
3.1.3 Global DNA Repair Drugs Market Concentration Ratio (CR5 and HHI)
3.2 DNA Repair Drugs Revenue by Manufacturers
3.2.1 DNA Repair Drugs Revenue by Manufacturers (2014-2019)
3.2.2 DNA Repair Drugs Revenue Share by Manufacturers (2014-2019)
3.3 DNA Repair Drugs Price by Manufacturers
3.4 DNA Repair Drugs Manufacturing Base Distribution, Product Types
3.4.1 DNA Repair Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers DNA Repair Drugs Product Type
3.4.3 Date of International Manufacturers Enter into DNA Repair Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global DNA Repair Drugs Sales by Product
4.2 Global DNA Repair Drugs Revenue by Product
4.3 DNA Repair Drugs Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global DNA Repair Drugs Breakdown Data by End User
6 North America
6.1 North America DNA Repair Drugs by Countries
6.1.1 North America DNA Repair Drugs Sales by Countries
6.1.2 North America DNA Repair Drugs Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America DNA Repair Drugs by Product
6.3 North America DNA Repair Drugs by End User
7 Europe
7.1 Europe DNA Repair Drugs by Countries
7.1.1 Europe DNA Repair Drugs Sales by Countries
7.1.2 Europe DNA Repair Drugs Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe DNA Repair Drugs by Product
7.3 Europe DNA Repair Drugs by End User
8 Asia Pacific
8.1 Asia Pacific DNA Repair Drugs by Countries
8.1.1 Asia Pacific DNA Repair Drugs Sales by Countries
8.1.2 Asia Pacific DNA Repair Drugs Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific DNA Repair Drugs by Product
8.3 Asia Pacific DNA Repair Drugs by End User
9 Central & South America
9.1 Central & South America DNA Repair Drugs by Countries
9.1.1 Central & South America DNA Repair Drugs Sales by Countries
9.1.2 Central & South America DNA Repair Drugs Revenue by Countries
9.1.3 Brazil
9.2 Central & South America DNA Repair Drugs by Product
9.3 Central & South America DNA Repair Drugs by End User
10 Middle East and Africa
10.1 Middle East and Africa DNA Repair Drugs by Countries
10.1.1 Middle East and Africa DNA Repair Drugs Sales by Countries
10.1.2 Middle East and Africa DNA Repair Drugs Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa DNA Repair Drugs by Product
10.3 Middle East and Africa DNA Repair Drugs by End User
11 Company Profiles
11.1 4SC AG
11.1.1 4SC AG Company Details
11.1.2 Company Business Overview
11.1.3 4SC AG DNA Repair Drugs Sales, Revenue and Gross Margin (2014-2019)
11.1.4 4SC AG DNA Repair Drugs Products Offered
11.1.5 4SC AG Recent Development
11.2 ARCAGY/ GINECO GROUP
11.2.1 ARCAGY/ GINECO GROUP Company Details
11.2.2 Company Business Overview
11.2.3 ARCAGY/ GINECO GROUP DNA Repair Drugs Sales, Revenue and Gross Margin (2014-2019)
11.2.4 ARCAGY/ GINECO GROUP DNA Repair Drugs Products Offered
11.2.5 ARCAGY/ GINECO GROUP Recent Development
11.3 Bristol Myers Squibb
11.3.1 Bristol Myers Squibb Company Details
11.3.2 Company Business Overview
11.3.3 Bristol Myers Squibb DNA Repair Drugs Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Bristol Myers Squibb DNA Repair Drugs Products Offered
11.3.5 Bristol Myers Squibb Recent Development
11.4 British Columbia Cancer Agency
11.4.1 British Columbia Cancer Agency Company Details
11.4.2 Company Business Overview
11.4.3 British Columbia Cancer Agency DNA Repair Drugs Sales, Revenue and Gross Margin (2014-2019)
11.4.4 British Columbia Cancer Agency DNA Repair Drugs Products Offered
11.4.5 British Columbia Cancer Agency Recent Development
11.5 Cambridge University Hospitals NHS Foundation Trust
11.5.1 Cambridge University Hospitals NHS Foundation Trust Company Details
11.5.2 Company Business Overview
11.5.3 Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Products Offered
11.5.5 Cambridge University Hospitals NHS Foundation Trust Recent Development
11.6 Genentech
11.6.1 Genentech Company Details
11.6.2 Company Business Overview
11.6.3 Genentech DNA Repair Drugs Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Genentech DNA Repair Drugs Products Offered
11.6.5 Genentech Recent Development
11.7 Georgetown University
11.7.1 Georgetown University Company Details
11.7.2 Company Business Overview
11.7.3 Georgetown University DNA Repair Drugs Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Georgetown University DNA Repair Drugs Products Offered
11.7.5 Georgetown University Recent Development
11.8 German Breast Group
11.8.1 German Breast Group Company Details
11.8.2 Company Business Overview
11.8.3 German Breast Group DNA Repair Drugs Sales, Revenue and Gross Margin (2014-2019)
11.8.4 German Breast Group DNA Repair Drugs Products Offered
11.8.5 German Breast Group Recent Development
11.9 GlaxoSmithKline
11.9.1 GlaxoSmithKline Company Details
11.9.2 Company Business Overview
11.9.3 GlaxoSmithKline DNA Repair Drugs Sales, Revenue and Gross Margin (2014-2019)
11.9.4 GlaxoSmithKline DNA Repair Drugs Products Offered
11.9.5 GlaxoSmithKline Recent Development
11.10 Jiangsu Hengrui Medicine
11.10.1 Jiangsu Hengrui Medicine Company Details
11.10.2 Company Business Overview
11.10.3 Jiangsu Hengrui Medicine DNA Repair Drugs Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Jiangsu Hengrui Medicine DNA Repair Drugs Products Offered
11.10.5 Jiangsu Hengrui Medicine Recent Development
11.11 Johnson & Johnson
11.12 Jonsson Comprehensive Cancer Center
11.13 Karyopharm Therapeutics
11.14 KuDOS Pharmaceuticals
11.15 National Health Service
11.16 National Institutes of Health
11.17 Tesaro
12 Future Forecast
12.1 DNA Repair Drugs Market Forecast by Regions
12.1.1 Global DNA Repair Drugs Sales Forecast by Regions 2019-2025
12.1.2 Global DNA Repair Drugs Revenue Forecast by Regions 2019-2025
12.2 DNA Repair Drugs Market Forecast by Product
12.2.1 Global DNA Repair Drugs Sales Forecast by Product 2019-2025
12.2.2 Global DNA Repair Drugs Revenue Forecast by Product 2019-2025
12.3 DNA Repair Drugs Market Forecast by End User
12.4 North America DNA Repair Drugs Forecast
12.5 Europe DNA Repair Drugs Forecast
12.6 Asia Pacific DNA Repair Drugs Forecast
12.7 Central & South America DNA Repair Drugs Forecast
12.8 Middle East and Africa DNA Repair Drugs Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 DNA Repair Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
Figure DNA Repair Drugs Product Picture
Table DNA Repair Drugs Market Segments
Table Key Manufacturers DNA Repair Drugs Covered
Table Global DNA Repair Drugs Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global DNA Repair Drugs Sales Market Share by Product 2014-2025
Figure PARP Inhibitors Product Picture
Table Major Manufacturers of PARP Inhibitors
Figure Other Product Picture
Table Major Manufacturers of Other
Table Global DNA Repair Drugs Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Oncological
Figure Stroke
Figure DNA Repair Drugs Report Years Considered
Figure Global DNA Repair Drugs Market Size 2014-2025 (Million US$)
Figure Global DNA Repair Drugs Sales 2014-2025 (K Units)
Table Global DNA Repair Drugs Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global DNA Repair Drugs Sales by Regions 2014-2019 (K Units)
Table Global DNA Repair Drugs Sales Market Share by Regions 2014-2019
Figure Global DNA Repair Drugs Sales Market Share by Regions 2014-2019
Figure 2018 Global DNA Repair Drugs Sales Market Share by Regions
Table Global DNA Repair Drugs Revenue by Regions 2014-2019 (Million US$)
Table Global DNA Repair Drugs Revenue Market Share by Regions 2014-2019
Figure Global DNA Repair Drugs Revenue Market Share by Regions 2014-2019
Figure 2018 Global DNA Repair Drugs Revenue Market Share by Regions
Table Global DNA Repair Drugs Sales by Manufacturers (2014-2019) (K Units)
Table Global DNA Repair Drugs Sales Share by Manufacturers (2014-2019)
Figure Global DNA Repair Drugs Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table DNA Repair Drugs Revenue by Manufacturers (2014-2019) (Million USD)
Table DNA Repair Drugs Revenue Share by Manufacturers (2014-2019)
Figure DNA Repair Drugs Value Share by Manufacturers in 2018
Table Key Manufacturers DNA Repair Drugs Price (2014-2019) (USD/Unit)
Table DNA Repair Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers DNA Repair Drugs Product Type
Table Date of International Manufacturers Enter into DNA Repair Drugs Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global DNA Repair Drugs Sales by Product (2014-2019) (K Units)
Table Global DNA Repair Drugs Sales Share by Product (2014-2019)
Figure Global DNA Repair Drugs Sales Market Share by Product (2014-2019)
Figure Global DNA Repair Drugs Sales Market Share by Product in 2018
Table Global DNA Repair Drugs Revenue by Product (2014-2019) (Million US$)
Table Global DNA Repair Drugs Revenue Share by Product (2014-2019)
Figure Global DNA Repair Drugs Revenue Market Share by Product (2014-2019)
Figure Global DNA Repair Drugs Revenue Market Share by Product in 2018
Table DNA Repair Drugs Price by Product 2014-2019 (USD/Unit)
Table Global DNA Repair Drugs Sales by End User (2014-2019) (K Units)
Table Global DNA Repair Drugs Sales Share by End User (2014-2019)
Figure Global Sales DNA Repair Drugs Market Share by End User (2014-2019)
Figure Global Sales DNA Repair Drugs Market Share by End User in 2018
Figure North America DNA Repair Drugs Sales Growth Rate 2014-2019 (K Units)
Figure North America DNA Repair Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table North America DNA Repair Drugs Sales by Countries (2014-2019) (K Units)
Table North America DNA Repair Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 North America DNA Repair Drugs Sales Market Share by Countries
Table North America DNA Repair Drugs Revenue by Countries (2014-2019) (Million US$)
Table North America DNA Repair Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 North America DNA Repair Drugs Revenue Market Share by Countries
Figure United States DNA Repair Drugs Sales Growth Rate (2014-2019) (K Units)
Figure United States DNA Repair Drugs Revenue Growth Rate (2014-2019) (K Units)
Figure Canada DNA Repair Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Canada DNA Repair Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico DNA Repair Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Mexico DNA Repair Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table North America DNA Repair Drugs Sales by Product (2014-2019) (K Units)
Table North America DNA Repair Drugs Sales Market Share by Product (2014-2019)
Figure 2018 North America DNA Repair Drugs Market Share by Product
Table North America DNA Repair Drugs Sales by End User (2014-2019) (K Units)
Table North America DNA Repair Drugs Sales Market Share by End User (2014-2019)
Figure 2018 North America DNA Repair Drugs Market Share by End User
Figure Europe DNA Repair Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Europe DNA Repair Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Europe DNA Repair Drugs Sales by Countries (2014-2019) (K Units)
Table Europe DNA Repair Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Europe DNA Repair Drugs Sales Market Share by Countries
Table Europe DNA Repair Drugs Revenue by Countries (2014-2019) (Million US$)
Table Europe DNA Repair Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe DNA Repair Drugs Revenue Market Share by Countries
Figure Germany DNA Repair Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Germany DNA Repair Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure France DNA Repair Drugs Sales Growth Rate (2014-2019) (K Units)
Figure France DNA Repair Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure UK DNA Repair Drugs Sales Growth Rate (2014-2019) (K Units)
Figure UK DNA Repair Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy DNA Repair Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Italy DNA Repair Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia DNA Repair Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Russia DNA Repair Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Europe DNA Repair Drugs Sales by Product (2014-2019) (K Units)
Table Europe DNA Repair Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Europe DNA Repair Drugs Market Share by Product
Table Europe DNA Repair Drugs Sales by End User (2014-2019) (K Units)
Table Europe DNA Repair Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Europe DNA Repair Drugs Market Share by End User
Figure Asia Pacific DNA Repair Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific DNA Repair Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific DNA Repair Drugs Sales by Countries (2014-2019) (K Units)
Table Asia Pacific DNA Repair Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific DNA Repair Drugs Sales Market Share by Countries
Table Asia Pacific DNA Repair Drugs Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific DNA Repair Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific DNA Repair Drugs Revenue Market Share by Countries
Figure China DNA Repair Drugs Sales Growth Rate (2014-2019) (K Units)
Figure China DNA Repair Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan DNA Repair Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Japan DNA Repair Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea DNA Repair Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Korea DNA Repair Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure India DNA Repair Drugs Sales Growth Rate (2014-2019) (K Units)
Figure India DNA Repair Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia DNA Repair Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Australia DNA Repair Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia DNA Repair Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia DNA Repair Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia DNA Repair Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia DNA Repair Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines DNA Repair Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Philippines DNA Repair Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand DNA Repair Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Thailand DNA Repair Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam DNA Repair Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam DNA Repair Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore DNA Repair Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Singapore DNA Repair Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific DNA Repair Drugs Sales by Product (2014-2019) (K Units)
Table Asia Pacific DNA Repair Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific DNA Repair Drugs Market Share by Product
Table Asia Pacific DNA Repair Drugs Sales by End User (2014-2019) (K Units)
Table Asia Pacific DNA Repair Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific DNA Repair Drugs Market Share by End User
Figure Central & South America DNA Repair Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America DNA Repair Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America DNA Repair Drugs Sales by Countries (2014-2019) (K Units)
Table Central & South America DNA Repair Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America DNA Repair Drugs Sales Market Share by Countries
Table Central & South America DNA Repair Drugs Revenue by Countries (2014-2019) (Million US$)
Table Central & South America DNA Repair Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America DNA Repair Drugs Revenue Market Share by Countries
Figure Brazil DNA Repair Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Brazil DNA Repair Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina DNA Repair Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Argentina DNA Repair Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America DNA Repair Drugs Sales by Product (2014-2019) (K Units)
Table Central & South America DNA Repair Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America DNA Repair Drugs Market Share by Product
Table Central & South America DNA Repair Drugs Sales by End User (2014-2019) (K Units)
Table Central & South America DNA Repair Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America DNA Repair Drugs Market Share by End User
Figure Middle East and Africa DNA Repair Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa DNA Repair Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa DNA Repair Drugs Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa DNA Repair Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa DNA Repair Drugs Sales Market Share by Countries
Table Middle East and Africa DNA Repair Drugs Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa DNA Repair Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa DNA Repair Drugs Revenue Market Share by Countries
Figure GCC Countries DNA Repair Drugs Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries DNA Repair Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey DNA Repair Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Turkey DNA Repair Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt DNA Repair Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Egypt DNA Repair Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa DNA Repair Drugs Sales Growth Rate (2014-2019) (K Units)
Figure South Africa DNA Repair Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa DNA Repair Drugs Sales by Product (2014-2019) (K Units)
Table Middle East and Africa DNA Repair Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa DNA Repair Drugs Market Share by Product
Table Middle East and Africa DNA Repair Drugs Sales by End User (2014-2019) (K Units)
Table Middle East and Africa DNA Repair Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa DNA Repair Drugs Market Share by End User
Table 4SC AG Company Details
Table 4SC AG DNA Repair Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table 4SC AG Recent Development
Table ARCAGY/ GINECO GROUP Company Details
Table ARCAGY/ GINECO GROUP DNA Repair Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table ARCAGY/ GINECO GROUP Recent Development
Table Bristol Myers Squibb Company Details
Table Bristol Myers Squibb DNA Repair Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Bristol Myers Squibb Recent Development
Table British Columbia Cancer Agency Company Details
Table British Columbia Cancer Agency DNA Repair Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table British Columbia Cancer Agency Recent Development
Table Cambridge University Hospitals NHS Foundation Trust Company Details
Table Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Cambridge University Hospitals NHS Foundation Trust Recent Development
Table Genentech Company Details
Table Genentech DNA Repair Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Genentech Recent Development
Table Georgetown University Company Details
Table Georgetown University DNA Repair Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Georgetown University Recent Development
Table German Breast Group Company Details
Table German Breast Group DNA Repair Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table German Breast Group Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline DNA Repair Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table GlaxoSmithKline Recent Development
Table Jiangsu Hengrui Medicine Company Details
Table Jiangsu Hengrui Medicine DNA Repair Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Jiangsu Hengrui Medicine Recent Development
Table Johnson & Johnson Company Details
Table Jonsson Comprehensive Cancer Center Company Details
Table Karyopharm Therapeutics Company Details
Table KuDOS Pharmaceuticals Company Details
Table National Health Service Company Details
Table National Institutes of Health Company Details
Table Tesaro Company Details
Table Global DNA Repair Drugs Sales Forecast by Regions 2019-2025 (K Units)
Table Global DNA Repair Drugs Sales Market Share Forecast by Regions 2019-2025
Table Global DNA Repair Drugs Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global DNA Repair Drugs Revenue Market Share Forecast by Regions 2019-2025
Table Global DNA Repair Drugs Sales Forecast by Product 2019-2025 (K Units)
Table Global DNA Repair Drugs Sales Market Share Forecast by Product 2019-2025
Table Global DNA Repair Drugs Revenue Forecast by Product 2019-2025 (Million US$)
Table Global DNA Repair Drugs Revenue Market Share Forecast by Product 2019-2025
Table Global DNA Repair Drugs Sales Forecast by End User 2019-2025 (K Units)
Table Global DNA Repair Drugs Sales Market Share Forecast by End User 2019-2025
Figure North America DNA Repair Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America DNA Repair Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe DNA Repair Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe DNA Repair Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific DNA Repair Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific DNA Repair Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America DNA Repair Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America DNA Repair Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa DNA Repair Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa DNA Repair Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table DNA Repair Drugs Value Chain
Table DNA Repair Drugs Customers List
Table DNA Repair Drugs Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global 5-Fluorouracil Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 76
    The global 5-Fluorouracil market was valued at US$ 283 million in 2023 and is anticipated to reach US$ 487.9 million by 2030, witnessing a CAGR of 4.3% during The forecast period 2024-2030. North American market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by ......
  • Global Carboplatin Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global Carboplatin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % d......
  • Global Neutropenia Drugs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 96
    The global Neutropenia Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated to increa......
  • Global Small Molecule Cancer Drug Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Small Molecule Cancer Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated ......
  • Global Capecitabine Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 80
    Capecitabine is an orally-administered chemotherapeutic agent used in The treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in The tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. Common side effects include abdominal pain, vomiting, diarrhea, weakness, and rashes. Other severe side effects include blood clotting problems, allergic reactions, heart problems, and low blo......
  • Global Oxaliplatin Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 104
    Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy The third stage colon cancer after resecting primary tumor completely. In this report, only The finished drug is covered, exclude API. The global Oxaliplatin market was valued at US$ 897.5 million in 2023 and is anticipated to reach US$ 1641.5 million by 2030, witnessing a CAGR of 8.9% duri......
  • Global Cancer Treatment Drugs Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 158
    According to our LPI (LP Information) latest study, the global Cancer Treatment Drugs market size was valued at US$ 174990 million in 2023. With growing demand in downstream market, the Cancer Treatment Drugs is forecast to a readjusted size of US$ 322540 million by 2030 with a CAGR of 9.1% during review period. The research report highlights the growth potential of the global Cancer Treatment Drugs market. Cancer Treatment Drugs are expected to show stable growth in the future market. H......
  • Global Capecitabine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 93
    According to our LPI (LP Information) latest study, the global Capecitabine market size was valued at US$ 1003.9 million in 2023. With growing demand in downstream market, the Capecitabine is forecast to a readjusted size of US$ 975.1 million by 2030 with a CAGR of -0.4% during review period. The research report highlights the growth potential of the global Capecitabine market. Capecitabine are expected to show stable growth in the future market. However, product differentiation, reducin......
  • Global Methotrexate Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95
    According to our LPI (LP Information) latest study, the global Methotrexate market size was valued at US$ 506 million in 2023. With growing demand in downstream market, the Methotrexate is forecast to a readjusted size of US$ 613.9 million by 2030 with a CAGR of 2.8% during review period. The research report highlights the growth potential of the global Methotrexate market. Methotrexate are expected to show stable growth in the future market. However, product differentiation, reducing co......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs